Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

300
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
300
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

501
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
501
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

673
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
673
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

2.0K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.0K
Drug Therapy01:28

Drug Therapy

83
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
83
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Eccentricity-Dependent Reflectivity Rates-of-Change Across the Retina in Intermediate Age-Related Macular Degeneration.

Investigative ophthalmology & visual science·2026
Same author

A new <sup>68</sup>Ga-labeled dimeric FAP ligand to advance targeted PET imaging of cancer.

EJNMMI radiopharmacy and chemistry·2026
Same author

Don't Use the Rapid Mood Screener Without Modifications for Greater Sensitivity.

Bipolar disorders·2026
Same author

A Threshold in Anti-EBNA-1 Antibody Titers Distinguishes Salivary EBV Shedders From Nonshedders.

The Journal of infectious diseases·2026
Same author

Clinical implications of improved risk prediction of continuous FFR<sub>CT</sub> by accounting for adverse coronary atherosclerotic features.

The international journal of cardiovascular imaging·2025
Same author

Multisystem Immune-Related Adverse Events Following Pembrolizumab: A Critical Care Case of Myocarditis, Diabetic Ketoacidosis, and CNS Demyelination.

Cureus·2025
Same journal

Characteristics of Children Seeking Care at School-Based Health Centers.

Journal of the American Board of Family Medicine : JABFM·2026
Same journal

An Analysis of Common Questions and Concerns of Older Adults with Multiple Chronic Conditions.

Journal of the American Board of Family Medicine : JABFM·2026
Same journal

Primary HPV Testing for Cervical Cancer Screening Among Family Medicine Educators.

Journal of the American Board of Family Medicine : JABFM·2026
Same journal

"Hard Fork" for Family Medicine - Artificial Intelligence Will Change the Way We Experience Practice.

Journal of the American Board of Family Medicine : JABFM·2026
Same journal

The Importance of Primary Care Subject Matter Experts: Output Quality in Large Language Models Prompt Engineering.

Journal of the American Board of Family Medicine : JABFM·2026
Same journal

Daily Nutrient Intake and Inflammation Among US Adults.

Journal of the American Board of Family Medicine : JABFM·2026
See all related articles

Related Experiment Video

Updated: Aug 14, 2025

Treating Clinical Depression with Repetitive Deep Transcranial Magnetic Stimulation Using the Brainsway H1-coil
09:30

Treating Clinical Depression with Repetitive Deep Transcranial Magnetic Stimulation Using the Brainsway H1-coil

Published on: October 4, 2016

22.4K

Antidepressant Tapering Is Not Routine But Could Be.

James Phelps1, James Nguyen1, Olivia Pipitone Coskey1

  • 1From Samaritan Mental Health, Samaritan Health Services, Corvallis, Oregon (JP); Western University School of Medicine, Lebanon, Oregon (JN); Graduate Medical Education, Samaritan Health Services, Corvallis, Oregon (OPC).

Journal of the American Board of Family Medicine : JABFM
|January 18, 2023
PubMed
Summary
This summary is machine-generated.

Antidepressant discontinuation can cause severe withdrawal symptoms. Careful dose tapering, while beneficial for some, is infrequent, with only 8.9% of patients showing evidence of tapering over seven years.

Keywords:
AntidepressantsAnxiety DisordersBipolar DisorderDepressionDrug TaperingMental HealthPrimary Health CarePsychiatry

More Related Videos

The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression
10:29

The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression

Published on: November 12, 2010

39.9K
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

28.7K

Related Experiment Videos

Last Updated: Aug 14, 2025

Treating Clinical Depression with Repetitive Deep Transcranial Magnetic Stimulation Using the Brainsway H1-coil
09:30

Treating Clinical Depression with Repetitive Deep Transcranial Magnetic Stimulation Using the Brainsway H1-coil

Published on: October 4, 2016

22.4K
The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression
10:29

The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression

Published on: November 12, 2010

39.9K
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

28.7K

Area of Science:

  • Psychiatry
  • Pharmacology
  • Clinical Medicine

Background:

  • Antidepressant discontinuation can lead to severe withdrawal symptoms in some patients.
  • Careful dose tapering is a strategy to minimize or prevent these withdrawal effects.
  • The frequency of deliberate antidepressant tapering in clinical practice is not well-established.

Purpose of the Study:

  • To determine the percentage of patients who received a prescription for the lowest available dose of their antidepressant before discontinuation, as an indicator of a deliberate taper.
  • To analyze trends in antidepressant tapering over a seven-year period.

Main Methods:

  • Retrospective analysis of seven years of medical records.
  • Identification of patients discontinuing antidepressant medication.
  • Assessment of tapering by examining prescriptions for the lowest available dose prior to discontinuation.

Main Results:

  • Only 8.9% of patients exhibited evidence of tapering over the seven-year study period.
  • The rate of tapering increased from 4.9% in 2014 to approximately 10% in the subsequent four years.
  • A significant majority of patients did not show evidence of a deliberate tapering process.

Conclusions:

  • While severe withdrawal symptoms are recognized, many patients may discontinue antidepressants without a formal taper.
  • Identifying patients who will struggle with discontinuation is challenging.
  • A standardized "one-size-fits-all" tapering approach, starting with a small dose reduction, is recommended to balance efficacy and simplicity.